UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 15

 

CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER
SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY
TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE
ACT OF 1934

 

Commission File Number: 001-40030

 

Decibel Therapeutics, Inc.

(Exact name of registrant as specified in its charter)

 

1325 Boylston Street, Suite 500

Boston, MA 02215

(617) 370-8701

(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)

 

Common Stock, par value $0.001 per share

(Title of each class of securities covered by this Form)

 

N/A

(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)

 

Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:

 

Rule 12g-4(a)(1) x
Rule 12g-4(a)(2) ¨
Rule 12h-3(b)(1)(i) x
Rule 12h-3(b)(1)(ii) ¨
Rule 15d-6 ¨
Rule 15d-22(b) ¨

 

Approximate number of holders of record as of the certification or notice date: one (1).

 

 

 

 

 

 

Pursuant to the requirements of the Securities Exchange Act of 1934, Decibel Therapeutics, Inc. has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.

 

Date:  October 10, 2023 Decibel Therapeutics, Inc.
     
  By:

/s/ Nouhad Husseini

  Name: Nouhad Husseini
  Title: Managing Director

 

 

 

Decibel Therapeutics (NASDAQ:DBTX)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Decibel Therapeutics Charts.
Decibel Therapeutics (NASDAQ:DBTX)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Decibel Therapeutics Charts.